Early impact of PCV7/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study-Reference-Cited by-同舟云学术

Early impact of PCV7/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study

Published:2015-02 Issue:9 Volume:33 Page:1135-1142
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Regev-Yochay Gili,Paran Yael,Bishara Jihad,Oren Ilana,Chowers Michal,Tziba Yevgenia,Istomin Valery,Weinberger Miriam,Miron Dan,Temper Violeta,Rahav Galia,Dagan Ron

Funder

Wyeth

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference23 articles.

1. Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention;Lynch;Semin Respir Crit Care Med,2009

2. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine;Pilishvili;J Infect Dis,2010

3. Epidemiology of invasive pneumococcal disease among adult patients in barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997–2007;Ardanuy;Clin Infect Dis,2009

4. The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes;Lehmann;Clin Infect Dis,2010

5. Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children;van der Linden;Vaccine,2012

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamics of invasive pneumococcal disease in infants < 2 years old following PCV7/13 implementation using two infant and a booster dose schedule: evidence for indirect protection of young infants, Israel, 2004 to 2019;Eurosurveillance;2023-06-22

2. Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021;EUROSURVEILLANCE;2023

3. Constrained Optimization for Pneumococcal Vaccination in Brazil;Value in Health Regional Issues;2021-12

4. Epidemiology of non-vaccine serotypes of Streptococcus pneumoniae before and after universal administration of pneumococcal conjugate vaccines;Human Vaccines & Immunotherapeutics;2021-11-02

5. Dynamics of Invasive Pneumococcal Disease in Israel in Children and Adults in the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Era: A Nationwide Prospective Surveillance;Clinical Infectious Diseases;2021-07-22